MODERATE TO SEVERE OPIOID USE DISORDER
Clinical trials for MODERATE TO SEVERE OPIOID USE DISORDER explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE OPIOID USE DISORDER trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE OPIOID USE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Long-Acting shot tested for opioid addiction
Disease control CompletedThis study tested a new long-acting injectable medication called INDV-6001 for adults with moderate to severe opioid addiction. The goal was to see how the drug behaves in the body, how safe it is, and to find the best dose for future studies. Researchers compared it to existing …
Matched conditions: MODERATE TO SEVERE OPIOID USE DISORDER
Phase: PHASE2 • Sponsor: Indivior Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Monthly shot tested to curb opioid cravings in High-Risk adults
Disease control CompletedThis study tested two different monthly doses of a long-acting buprenorphine injection to help control opioid addiction. It involved 785 adults with moderate-to-severe opioid use disorder who were considered high-risk users. The main goal was to see which monthly dose was better …
Matched conditions: MODERATE TO SEVERE OPIOID USE DISORDER
Phase: PHASE4 • Sponsor: Indivior Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC